Search

Search results

92 results found

Suppression of Wnt signaling by the green tea compound (-)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells. Requirement of the transcriptional repressor HBP1.

Publication: Journal Article

Kim, Jiyoung, Xiaowei Zhang, Kimberly M Rieger-Christ, Ian C Summerhayes, David E Wazer, Eric Paulson, and Amy S Yee. 2006. “Suppression of Wnt Signaling by the Green Tea Compound (-)-Epigallocatechin 3-Gallate (EGCG) in Invasive Breast Cancer Cells. Requirement of the Transcriptional Repressor HBP1.”. The Journal of Biological Chemistry 281 (16): 10865-75.

Efficacy of combination gene therapy with multiple growth factor cDNAs to enhance skin flap survival in a rat model.

Publication: Journal Article

Liu, Paul Y, Kan Liu, Xiao Tian Wang, Evangelos Badiavas, Kimberly M Rieger-Christ, Jin Bo Tang, and Ian C Summerhayes. 2005. “Efficacy of Combination Gene Therapy With Multiple Growth Factor CDNAs to Enhance Skin Flap Survival in a Rat Model.”. DNA and Cell Biology 24 (11): 751-7.

Novel expression of N-cadherin elicits in vitro bladder cell invasion via the Akt signaling pathway.

Publication: Journal Article

Rieger-Christ, Kimberly M, Peter Lee, Ralph Zagha, Monika Kosakowski, Alireza Moinzadeh, John Stoffel, Avri Ben-Ze’ev, John A Libertino, and Ian C Summerhayes. 2004. “Novel Expression of N-Cadherin Elicits in Vitro Bladder Cell Invasion via the Akt Signaling Pathway.”. Oncogene 23 (27): 4745-53.

Enhanced peripheral nerve regeneration elicited by cell-mediated events delivered via a bioresorbable PLGA guide.

Publication: Journal Article

Bryan, David J, Jin Bo Tang, Antonia H Holway, Kimberly M Rieger-Christ, Debra J Trantolo, Donald L Wise, and Ian C Summerhayes. 2003. “Enhanced Peripheral Nerve Regeneration Elicited by Cell-Mediated Events Delivered via a Bioresorbable PLGA Guide.”. Journal of Reconstructive Microsurgery 19 (2): 125-34.

Team

Page

Travis Sullivan

Person: Associate Director, Translational Research

Travis Sullivan is the Associate Director Of Translational Research at LHMC. He has thirteen years of experience in the Biotech industry developing biomarker assays, 10+ years of research efforts in Translational Research, two patents related to assay design, and over 30 publications in these fields...

New Publication to Cancers Special Issue Time for a Paradigm Shift in Non-muscle-invasive Bladder Cancer (Volume II)

News: May 11, 2024

Thanks to the efforts of all involved, we have just published a paper, "Treatment Modalities for Non-Muscle Invasive Bladder Cancer: An Updated Review" to Cancers Special Issue Time for a Paradigm Shift in Non-muscle-invasive Bladder Cancer (Volume II). Read Here

LuCNeSS Presentation at the 2024 Rescue Lung Rescue Life Conference

News: October 26, 2024

This year we were honored to have AJ Piper-Vallillo, MD present on LuCNeSS at the 2024 Rescue Lung Rescue Life Conference. This presentation highlighted our domestic LuCNeSS study and our World LuCNeSS study, as well was the study's preliminary results. Piper-Vallillo, AJ. Lung Cancer in those who...

Lung Health Foundation Presentation

News: February 11, 2025

On 11 February 2025, Dr. Carl Martin Tammemägi presented on the LuCNeSS study to the Lung Health Foundation. Tammemägi, Carl Martin. Identification of never smoking individuals at high risk for lung cancer. Presented to the Lung Health Foundation in Toronto, 11 February 2025. Toronto, Ontario...

Capacity assessment for EHR-based medical device post-market surveillance for synthetic mid-urethral slings among women with stress urinary incontinence: a NEST consortium study.

Publication: Journal Article

Matheny, Michael E, Amy M Perkins, Kimberly Rieger-Christ, Joseph S Ross, Jialin Mao, Art Sedrakyan, Nilay D Shah, et al. 2025. “Capacity Assessment for EHR-Based Medical Device Post-Market Surveillance for Synthetic Mid-Urethral Slings Among Women With Stress Urinary Incontinence: A NEST Consortium Study.”. BMJ Surgery, Interventions, & Health Technologies 7 (1): e000193.